NO308236B1 - Farmasøytisk blanding inneholdende indolderivater - Google Patents

Farmasøytisk blanding inneholdende indolderivater

Info

Publication number
NO308236B1
NO308236B1 NO954287A NO954287A NO308236B1 NO 308236 B1 NO308236 B1 NO 308236B1 NO 954287 A NO954287 A NO 954287A NO 954287 A NO954287 A NO 954287A NO 308236 B1 NO308236 B1 NO 308236B1
Authority
NO
Norway
Prior art keywords
pharmaceutical composition
composition containing
indole derivatives
containing indole
derivatives
Prior art date
Application number
NO954287A
Other languages
English (en)
Other versions
NO954287L (no
NO954287D0 (no
Inventor
John Eugene Macor
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO954287L publication Critical patent/NO954287L/no
Publication of NO954287D0 publication Critical patent/NO954287D0/no
Publication of NO308236B1 publication Critical patent/NO308236B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO954287A 1993-04-27 1995-10-26 Farmasøytisk blanding inneholdende indolderivater NO308236B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5393093A 1993-04-27 1993-04-27
PCT/IB1994/000079 WO1994025023A1 (en) 1993-04-27 1994-04-26 Use of indole derivatives as 5ht1 antagonists

Publications (3)

Publication Number Publication Date
NO954287L NO954287L (no) 1995-10-26
NO954287D0 NO954287D0 (no) 1995-10-26
NO308236B1 true NO308236B1 (no) 2000-08-21

Family

ID=21987528

Family Applications (1)

Application Number Title Priority Date Filing Date
NO954287A NO308236B1 (no) 1993-04-27 1995-10-26 Farmasøytisk blanding inneholdende indolderivater

Country Status (29)

Country Link
EP (1) EP0696194B1 (no)
JP (1) JP2922307B2 (no)
KR (1) KR960701636A (no)
CN (3) CN1121689A (no)
AP (1) AP486A (no)
AT (1) ATE222492T1 (no)
AU (1) AU689469B2 (no)
BG (1) BG61898B1 (no)
BR (1) BR9406435A (no)
CA (1) CA2161533C (no)
CO (1) CO4230093A1 (no)
CZ (1) CZ290416B6 (no)
DE (1) DE69431201T2 (no)
DK (1) DK0696194T3 (no)
ES (1) ES2180573T3 (no)
HU (1) HU222488B1 (no)
IL (1) IL109376A (no)
MX (1) MX9403088A (no)
NO (1) NO308236B1 (no)
NZ (1) NZ263614A (no)
OA (1) OA10189A (no)
PL (1) PL175156B1 (no)
PT (1) PT696194E (no)
RO (1) RO117760B1 (no)
RU (1) RU2132683C1 (no)
SG (1) SG43951A1 (no)
SK (1) SK283353B6 (no)
WO (1) WO1994025023A1 (no)
ZA (1) ZA942805B (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5559129A (en) * 1990-10-15 1996-09-24 Pfizer Inc Indole derivatives
US5545644A (en) * 1990-10-15 1996-08-13 Pfizer Inc. Indole derivatives
US5559246A (en) * 1990-10-15 1996-09-24 Pfizer Inc. Indole derivatives
US5578612A (en) * 1990-10-15 1996-11-26 Pfizer Inc. Indole derivatives
US5607951A (en) * 1990-10-15 1997-03-04 Pfizer Inc Indole derivatives
KR100191973B1 (ko) * 1993-08-31 1999-06-15 디. 제이. 우드, 스피겔 알렌 제이 5-아릴인돌 유도체
GB9417310D0 (en) 1994-08-27 1994-10-19 Pfizer Ltd Therapeutic agents
WO1996011923A1 (en) * 1994-10-12 1996-04-25 Pfizer Limited Indole derivative for the treatment of migraine
GB9424471D0 (en) * 1994-12-03 1995-01-18 Pfizer Ltd Treatment of emesis
GB9510223D0 (en) * 1995-05-20 1995-07-19 Pfizer Ltd Therapeutic agent
US5945118A (en) * 1995-09-29 1999-08-31 Pfizer Inc Indole derivative for the treatment of migraine
US5773015A (en) * 1996-11-27 1998-06-30 Elizabeth Arden Co., Division Of Conopco, Inc. Method for controlling skin oils and grease
GB9706089D0 (en) * 1997-03-24 1997-05-14 Scherer Ltd R P Pharmaceutical composition
US5994352A (en) * 1998-11-13 1999-11-30 Pfizer Inc. 5-arylindole derivatives
ES2199086B1 (es) * 2002-07-31 2005-06-01 Cepa Schwarz Pharma Sl Nuevos derivados de cicloalcanodionas, procedimiento para su preparacion y sus aplicaciones farmacologicas.
MX2022009528A (es) * 2020-02-04 2022-11-14 Mindset Pharma Inc Derivados de 3-pirrolidina-indol como agentes psicodélicos serotoninérgicos para el tratamiento de trastornos del snc.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2095360C1 (ru) * 1990-10-15 1997-11-10 Пфайзер Инк. Производные индола, их оптические изомеры и фармацевтически приемлемые соли
GB9102579D0 (en) * 1991-01-24 1991-03-27 Glaxo Group Ltd Compositions
GB9103770D0 (en) * 1991-02-22 1991-04-10 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
PL311266A1 (en) 1996-02-05
EP0696194A1 (en) 1996-02-14
CZ290416B6 (cs) 2002-07-17
CN1121689A (zh) 1996-05-01
ATE222492T1 (de) 2002-09-15
AU6436094A (en) 1994-11-21
HU222488B1 (hu) 2003-07-28
KR960701636A (ko) 1996-03-28
PT696194E (pt) 2002-11-29
CA2161533A1 (en) 1994-11-10
BR9406435A (pt) 1996-01-09
JPH08504829A (ja) 1996-05-28
EP0696194B1 (en) 2002-08-21
NZ263614A (en) 1998-02-26
ZA942805B (en) 1995-10-23
CN1509713A (zh) 2004-07-07
DE69431201T2 (de) 2002-12-05
AP9400633A0 (en) 1994-04-30
AP486A (en) 1996-04-16
CN1515252A (zh) 2004-07-28
BG100093A (bg) 1996-04-30
HU9503089D0 (en) 1995-12-28
OA10189A (en) 1996-12-18
HUT73670A (en) 1996-09-30
SK133295A3 (en) 1997-01-08
RO117760B1 (ro) 2002-07-30
CZ9502802A3 (en) 1996-04-17
IL109376A (en) 2000-10-31
SK283353B6 (sk) 2003-06-03
NO954287L (no) 1995-10-26
IL109376A0 (en) 1994-07-31
PL175156B1 (pl) 1998-11-30
DK0696194T3 (da) 2002-10-07
SG43951A1 (en) 1997-11-14
AU689469B2 (en) 1998-04-02
MX9403088A (es) 1997-02-28
BG61898B1 (bg) 1998-09-30
CA2161533C (en) 1998-08-04
CO4230093A1 (es) 1995-10-19
JP2922307B2 (ja) 1999-07-19
RU2132683C1 (ru) 1999-07-10
NO954287D0 (no) 1995-10-26
WO1994025023A1 (en) 1994-11-10
DE69431201D1 (de) 2002-09-26
ES2180573T3 (es) 2003-02-16

Similar Documents

Publication Publication Date Title
IL111314A (en) Pharmaceutical compositions containing indole derivatives
DK43193D0 (da) Indolderivater
FI944805A (fi) Indolijohdannaisia 5-HT1-kaltaisina agonisteina
PT589843E (pt) Composicoes farmaceuticas contendo ciclosporinas
FI944832A (fi) Farmaseuttinen koostumus
FI954767A (fi) Lipofiilisiä lääkeaineita sisältävä farmaseuttinen koostumus
CY2005007I1 (el) Φαρμακευτικες συνθεσεις που περιεχουν δαριφενακινη
IL105003A0 (en) Indole derivatives and pharmaceutical compositions containing them
NO961475L (no) Indol-derivater
NO308236B1 (no) Farmasøytisk blanding inneholdende indolderivater
DK0411150T3 (da) Indolderivater
DE69212058T2 (de) Indol-Derivate
ITMI932540A0 (it) Composizione farmaceutica
AU1256792A (en) Indole derivatives and pharmaceutical compositions containing them
EE9900206A (et) N-sulfonüülindoliiniderivaate sisaldavad farmatseutilised kompositsioonid
NO973656D0 (no) Farmasöytisk blanding for parenteral anvendelse inneholdende en indolkarboksylsyre
LV10579A (lv) Farmaceitiska kompozicija
FI953361A (fi) Menetelmä substituoitujen indolonijohdannaisten valmistamiseksi
FI934387A0 (fi) 3-substituerade 2-oxi-indol-1-karboxiamid omfattande farmaceutiska kompositioner
IL119844A (en) Substituted indole derivatives and pharmaceutical compositions containing them
IL110459A0 (en) Pharmaceutical or veterinary composition containing indole derivatives
IT1272935B (it) Composizione farmaceutica contenente n-acetil-cisteina
ITMI930181A1 (it) Composizione farmaceutica contenente n-acetil-cisteina
ITMI922581A0 (it) Composizione farmaceutica
SE9202820D0 (sv) Farmaceutisk komposition

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees